CIK 0001600620 · Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981231763
- Phone
- 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $546,373
- in 2 filings
Net −$546,373. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-06 | Robertson Stephen P. EVP, General Counsel | Sale | −57,745 | $5.60 | $323K | 443,824 |
| 2024-02-27 | Knappertz Volker EVP, Research and Development | Sale | −4,930 | $6.10 | $30K | 319,128 |
| 2024-02-20 | Knappertz Volker EVP, Research and Development | Sale | −25,146 | $5.48 | $138K | 324,058 |
| 2024-02-20 | Habig Scott Michael Chief Commercial Officer | Grant or award | +195,512 | 508,231 | ||
| 2024-02-20 | Habig Scott Michael Chief Commercial Officer | Sale | −15,867 | $5.48 | $87K | 492,364 |
| 2024-02-20 | Donley Matthew Maxwell EVP, Ops & Strategy | Grant or award | +216,666 | 624,737 | ||
| 2024-02-20 | Robertson Stephen P. EVP, General Counsel | Grant or award | +194,230 | 501,569 | ||
| 2024-02-20 | Miller Joseph M Chief Financial Officer | Grant or award | +196,153 | 530,739 | ||
| 2024-02-20 | Greenleaf Peter Chief Executive Officer | Grant or award | +661,538 | 1,649,095 | ||
| 2023-09-21 | Foster Robert T Director | Grant or award · Restricted Stock Units | +20,383 | 20,383 | ||
| 2023-09-21 | Foster Robert T Director | Grant or award · Stock Option (right to buy) | +32,900 | 32,900 | ||
| 2023-08-18 | Bailey Jeffrey Allen Director | Grant or award · Restricted Stock Units | +17,913 | 17,913 | ||
| 2023-08-18 | Bailey Jeffrey Allen Director | Grant or award · Stock Option (right to buy) | +28,959 | 28,959 | ||
| 2023-08-18 | Smith Karen L. Director | Grant or award · Restricted Stock Units | +17,913 | 17,913 | ||
| 2023-08-18 | Smith Karen L. Director | Grant or award · Stock Option (right to buy) | +28,959 | 28,959 | ||
| 2023-05-23 | Jayne David R.W. Director | Sale | −8,733 | $11.26 | $98K | 49,310 |
| 2023-05-23 | Billen Daniel Director | Sale | −4,650 | $11.26 | $52K | 33,393 |
| 2023-05-23 | MacKay-Dunn R. Hector Director | Sale | −4,818 | $11.26 | $54K | 24,225 |
| 2023-05-23 | Leversage Jill Director | Sale | −4,815 | $11.26 | $54K | 18,528 |
| 2023-05-19 | Balakrishnan Brinda Director | Grant or award | +9,310 | 18,043 |
Page 7 of 10 · 197 trades